Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Postgraduate Medicine|December 1, 1996
Nephrolithiasis: how it happens and what to do about itB K TrivediJournal of Medicinal Chemistry|May 1, 1988
[1,2,4]Triazolo[4,3-a]quinoxalin-4-amines: a new class of A1 receptor selective adenosine antagonistsB K Trivedi, R F BrunsCurrent Pharmaceutical Design|March 6, 1999
15-Lipoxygenase and its inhibition: a novel therapeutic target for vascular diseaseJ A Cornicelli, B K TrivediJournal of Medicinal Chemistry|August 1, 1989
C2,N6-disubstituted adenosines: synthesis and structure-activity relationshipsB K Trivedi, R F BrunsJournal of Medicinal Chemistry|August 1, 1985
Stereoselective antitumor properties in the Lewis lung carcinoma model using bis(morpholinomethyl) derivatives of tricyclic bis(dioxopiperazines)D T Witiak, B K Trivedi, F A SchmidKidney International. Supplement|June 1, 1991
Application of polymerase chain reaction techniques to study of rabbit renin gene expressionB K Trivedi, J P Briggs, P D KillenKidney International|January 6, 2006
Association of anemia with outcomes in men with moderate and severe chronic kidney diseaseC P Kovesdy, B K Trivedi, K Kalantar-Zadeh, et al.Journal of Medicinal Chemistry|November 1, 1981
Synthesis and antimetastatic properties of steroeoisomeric trycylic bis(dioxopiperazine) analogues in a B16 melanoma modelD T Witiak, B K Trivedi, L B Campolito, et al.Journal of Medicinal Chemistry|January 1, 1988
N6-(arylalkyl)adenosines. Identification of N6-(9-fluorenylmethyl)adenosine as a highly potent agonist for the adenosine A2 receptorB K Trivedi, J A Bristol, R F Bruns, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1997
In vitro and in vivo disposition of 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide (CI-976). Identification of a novel five-carbon cleavage metabolite in ratsM W Sinz, A E Black, S M Bjorge, et al.Pageof 3